S&P 500   3,929.05 (-1.75%)
DOW   33,482.58 (-1.37%)
QQQ   280.44 (-2.50%)
AAPL   142.21 (-3.01%)
MSFT   244.18 (-2.41%)
META   114.12 (-6.79%)
GOOGL   96.74 (-2.75%)
AMZN   88.05 (-3.25%)
TSLA   177.97 (-2.46%)
NVDA   158.82 (-4.38%)
NIO   13.15 (+2.73%)
BABA   90.97 (+0.50%)
AMD   69.85 (-5.12%)
T   19.04 (+1.55%)
MU   53.31 (-1.35%)
CGC   3.57 (-17.36%)
F   13.11 (-2.02%)
GE   84.73 (+0.08%)
DIS   92.43 (-3.65%)
AMC   6.77 (-9.13%)
PYPL   71.65 (-2.68%)
PFE   49.62 (-2.19%)
NFLX   303.81 (-2.81%)
S&P 500   3,929.05 (-1.75%)
DOW   33,482.58 (-1.37%)
QQQ   280.44 (-2.50%)
AAPL   142.21 (-3.01%)
MSFT   244.18 (-2.41%)
META   114.12 (-6.79%)
GOOGL   96.74 (-2.75%)
AMZN   88.05 (-3.25%)
TSLA   177.97 (-2.46%)
NVDA   158.82 (-4.38%)
NIO   13.15 (+2.73%)
BABA   90.97 (+0.50%)
AMD   69.85 (-5.12%)
T   19.04 (+1.55%)
MU   53.31 (-1.35%)
CGC   3.57 (-17.36%)
F   13.11 (-2.02%)
GE   84.73 (+0.08%)
DIS   92.43 (-3.65%)
AMC   6.77 (-9.13%)
PYPL   71.65 (-2.68%)
PFE   49.62 (-2.19%)
NFLX   303.81 (-2.81%)
S&P 500   3,929.05 (-1.75%)
DOW   33,482.58 (-1.37%)
QQQ   280.44 (-2.50%)
AAPL   142.21 (-3.01%)
MSFT   244.18 (-2.41%)
META   114.12 (-6.79%)
GOOGL   96.74 (-2.75%)
AMZN   88.05 (-3.25%)
TSLA   177.97 (-2.46%)
NVDA   158.82 (-4.38%)
NIO   13.15 (+2.73%)
BABA   90.97 (+0.50%)
AMD   69.85 (-5.12%)
T   19.04 (+1.55%)
MU   53.31 (-1.35%)
CGC   3.57 (-17.36%)
F   13.11 (-2.02%)
GE   84.73 (+0.08%)
DIS   92.43 (-3.65%)
AMC   6.77 (-9.13%)
PYPL   71.65 (-2.68%)
PFE   49.62 (-2.19%)
NFLX   303.81 (-2.81%)
S&P 500   3,929.05 (-1.75%)
DOW   33,482.58 (-1.37%)
QQQ   280.44 (-2.50%)
AAPL   142.21 (-3.01%)
MSFT   244.18 (-2.41%)
META   114.12 (-6.79%)
GOOGL   96.74 (-2.75%)
AMZN   88.05 (-3.25%)
TSLA   177.97 (-2.46%)
NVDA   158.82 (-4.38%)
NIO   13.15 (+2.73%)
BABA   90.97 (+0.50%)
AMD   69.85 (-5.12%)
T   19.04 (+1.55%)
MU   53.31 (-1.35%)
CGC   3.57 (-17.36%)
F   13.11 (-2.02%)
GE   84.73 (+0.08%)
DIS   92.43 (-3.65%)
AMC   6.77 (-9.13%)
PYPL   71.65 (-2.68%)
PFE   49.62 (-2.19%)
NFLX   303.81 (-2.81%)
NASDAQ:OGI

OrganiGram - OGI Stock Forecast, Price & News

$1.02
-0.13 (-10.87%)
(As of 12/6/2022 02:29 PM ET)
Add
Compare
Today's Range
$1.01
$1.15
50-Day Range
$0.87
$1.19
52-Week Range
$0.84
$2.13
Volume
101,730 shs
Average Volume
1.18 million shs
Market Capitalization
$321.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.96

OrganiGram MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
193.1% Upside
$2.96 Price Target
Short Interest
Bearish
2.81% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.33mentions of OrganiGram in the last 14 days
Based on 14 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.05) to ($0.02) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.93 out of 5 stars

Medical Sector

669th out of 1,023 stocks

Pharmaceutical Preparations Industry

328th out of 501 stocks

OGI stock logo

About OrganiGram (NASDAQ:OGI) Stock

Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.

Receive OGI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrganiGram and its competitors with MarketBeat's FREE daily newsletter.

OGI Stock News Headlines

MarketBeat: Week in Review 11/28 – 12/02 (OGI)
Investors continue to monitor the Federal Reserve, but the MarketBeat team helps you look past the headlines. Here are the stories moving the market this week
Three Reasons It’s Time To Get Bullish On Organigram
Organigram is getting closer and closer to true profits and there are other catalysts in the works that will boost revenue and profitability over the long term.
OrganiGram (OGI) Set to Announce Quarterly Earnings on Monday
Organigram Holdings Inc. Common Shares (OGI)
See More Headlines
Receive OGI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrganiGram and its competitors with MarketBeat's FREE daily newsletter.

OGI Company Calendar

Last Earnings
7/12/2021
Today
12/06/2022
Next Earnings (Estimated)
1/09/2023
Fiscal Year End
8/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:OGI
Fax
N/A
Employees
841
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$2.96
High Stock Price Forecast
$5.30
Low Stock Price Forecast
$1.50
Forecasted Upside/Downside
+188.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-11,230,000.00
Pretax Margin
-9.86%

Debt

Sales & Book Value

Annual Sales
$111.27 million
Book Value
$1.27 per share

Miscellaneous

Free Float
N/A
Market Cap
$321.71 million
Optionable
Not Optionable
Beta
0.75

Key Executives

  • Mr. Derrick W. West CPA (Age 55)
    CPA, (CA), Chief Financial Officer
    Comp: $231.81k
  • Ms. Helen Martin (Age 44)
    Chief Legal Officer & Corp. Sec.
    Comp: $217.11k
  • Mr. Gregory Engel (Age 57)
    Special Advisor
    Comp: $434.3k
  • Mr. Timothy Emberg
    Chief Revenue Officer
  • Mr. Paolo De Luca C.A. (Age 49)
    C.F.A, Chief Strategy Officer
    Comp: $228.74k
  • Ms. Beena G. Goldenberg (Age 59)
    CEO & Director
  • Ms. Nathalie Batten
    VP of Operations
  • Amy Schwalm
    VP of Investor Relations
  • Ms. Megan Amber McCrae
    Sr. VP of Marketing & Communications
  • Tina Shannon
    VP of HR













OGI Stock - Frequently Asked Questions

Should I buy or sell OrganiGram stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OGI shares.
View OGI analyst ratings
or view top-rated stocks.

What is OrganiGram's stock price forecast for 2023?

4 equities research analysts have issued 1-year target prices for OrganiGram's shares. Their OGI share price forecasts range from $1.50 to $5.30. On average, they expect the company's share price to reach $2.96 in the next twelve months. This suggests a possible upside of 187.4% from the stock's current price.
View analysts price targets for OGI
or view top-rated stocks among Wall Street analysts.

How have OGI shares performed in 2022?

OrganiGram's stock was trading at $1.75 on January 1st, 2022. Since then, OGI stock has decreased by 41.1% and is now trading at $1.03.
View the best growth stocks for 2022 here
.

When is OrganiGram's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, January 9th 2023.
View our OGI earnings forecast
.

How were OrganiGram's earnings last quarter?

OrganiGram Holdings Inc. (NASDAQ:OGI) issued its earnings results on Monday, July, 12th. The company reported ($0.01) earnings per share for the quarter, beating analysts' consensus estimates of ($0.03) by $0.02. The company had revenue of $16.55 million for the quarter, compared to analyst estimates of $13.95 million. OrganiGram had a negative trailing twelve-month return on equity of 7.46% and a negative net margin of 9.79%.

What other stocks do shareholders of OrganiGram own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OrganiGram investors own include KushCo (KSHB), Auxly Cannabis Group (CBWTF), Supreme Cannabis (SPRWF), Medical Marijuana (MJNA), CNBX Pharmaceuticals (CNBX), MariMed (MRMD), Aurora Cannabis (ACB), EVIO (EVIO) and Gran Tierra Energy (GTE).

What is OrganiGram's stock symbol?

OrganiGram trades on the NASDAQ under the ticker symbol "OGI."

Who are OrganiGram's major shareholders?

OrganiGram's stock is owned by a number of retail and institutional investors. Top institutional shareholders include ETF Managers Group LLC (4.29%), Renaissance Technologies LLC (0.30%), Two Sigma Advisers LP (0.15%), Connor Clark & Lunn Investment Management Ltd. (0.12%), Royal Bank of Canada (0.03%) and Group One Trading L.P. (0.00%).

How do I buy shares of OrganiGram?

Shares of OGI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OrganiGram's stock price today?

One share of OGI stock can currently be purchased for approximately $1.03.

How much money does OrganiGram make?

OrganiGram (NASDAQ:OGI) has a market capitalization of $323.28 million and generates $111.27 million in revenue each year. The company earns $-11,230,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis.

How many employees does OrganiGram have?

The company employs 841 workers across the globe.

How can I contact OrganiGram?

OrganiGram's mailing address is 35 English Dr., Moncton Z4, E1E 3X3. The official website for the company is www.organigram.ca. The company can be reached via phone at (844) 644-4726.

This page (NASDAQ:OGI) was last updated on 12/6/2022 by MarketBeat.com Staff